Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Zyprexa

Executive Summary

Ivax is "first to file" an ANDA for generic olanzapine. The compound patent has protection through 2011, Lilly says. The application follows trend for companies to file after a product's four-year Waxman/Hatch prohibition on ANDA filings expires, Lilly says

You may also be interested in...



Lilly Zyprexa Patent Challenge Summary Judgment Motions Expected In June

Lilly expects to initiate summary judgment motions in June in consolidated patent litigation related to its antipsychotic Zyprexa, Senior VP & General Counsel Bob Armitage told investors in New York April 4

Lilly Zyprexa Patent Challenge Summary Judgment Motions Expected In June

Lilly expects to initiate summary judgment motions in June in consolidated patent litigation related to its antipsychotic Zyprexa, Senior VP & General Counsel Bob Armitage told investors in New York April 4

Zyprexa patent litigation

Lilly expects "a trial date to be scheduled for the fourth quarter of 2003" for consolidated patent litigation related to its antipsychotic Zyprexa, company says in second quarter 10-Q filing with Securities & Exchange Commission. Lilly filed an infringement suit against Zenith in Indianapolis federal court last year over an olanzapine patent set to expire in 2011; Ivax was "first to file" an ANDA for olanzapine in February 2001 (1"The Pink Sheet" Feb. 26, 2001, p. 32). Lilly was notified that Dr. Reddy's also filed an ANDA covering additional dosage forms of olanzapine in May 2001 and January 2002. "In February 2002, we filed an infringement suit in the same court based on Reddy's later ANDA. The Zenith and Reddy cases have been consolidated and are in the discovery stage," Lilly says...

Related Content

UsernamePublicRestriction

Register

PS037399

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel